# FDA recall D-0321-2024

> **Teva Pharmaceuticals USA, Inc** · Class III · drug recall initiated 2024-01-25.

## Product

Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9008-67

## Reason for recall

Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.

## Distribution

nationwide

## Key facts

- **Recall number:** D-0321-2024
- **Recalling firm:** Teva Pharmaceuticals USA, Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-01-25
- **Report date:** 2024-02-21

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0321-2024

## Citation

> AI Analytics. FDA recall D-0321-2024. Retrieved 2026-06-30 from https://api.ai-analytics.org/recall/D-0321-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*